BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29477291)

  • 1. Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group.
    Vargo JA; Moiseenko V; Grimm J; Caudell J; Clump DA; Yorke E; Xue J; Vinogradskiy Y; Moros EG; Mavroidis P; Jain S; El Naqa I; Marks LB; Heron DE
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):137-146. PubMed ID: 29477291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
    Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
    Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: A meta-analysis and systematic review.
    Lee J; Kim WC; Yoon WS; Koom WS; Rim CH
    Oral Oncol; 2020 Aug; 107():104757. PubMed ID: 32388412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2
    von der Grün J; Köhn J; Loutfi-Krauss B; Blanck O; Rödel C; Balermpas P
    Head Neck; 2019 Apr; 41(4):E48-E54. PubMed ID: 30521102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer.
    Chen YJ; Kuo JV; Ramsinghani NS; Al-Ghazi MS
    Med Dosim; 2002; 27(2):171-6. PubMed ID: 12074469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study.
    Diao K; Nguyen TP; Moreno AC; Reddy JP; Garden AS; Wang CH; Tung S; Wang C; Wang XA; Rosenthal DI; Fuller CD; Gunn GB; Frank SJ; Morrison WH; Shah SJ; Lee A; Spiotto MT; Su SY; Ferrarotto R; Phan J
    Head Neck; 2021 Nov; 43(11):3331-3344. PubMed ID: 34269492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
    Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
    Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence.
    Román A A; Jodar C; Perez-Rozos A; Lupiañez-Perez Y; Medina JA; Gomez-Millan J
    Crit Rev Oncol Hematol; 2018 Feb; 122():194-201. PubMed ID: 29373181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
    Baliga S; Kabarriti R; Ohri N; Haynes-Lewis H; Yaparpalvi R; Kalnicki S; Garg MK
    Head Neck; 2017 Mar; 39(3):595-601. PubMed ID: 27997054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic Body Radiotherapy Treatment for Recurrent, Previously Irradiated Head and Neck Cancer.
    Stanisce L; Koshkareva Y; Xu Q; Patel A; Squillante C; Ahmad N; Rajagopalan K; Kubicek GJ
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818780086. PubMed ID: 29890894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
    Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell Carcinoma.
    Quan K; Xu KM; Zhang Y; Clump DA; Flickinger JC; Lalonde R; Burton SA; Heron DE
    Semin Radiat Oncol; 2016 Apr; 26(2):112-9. PubMed ID: 27000507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck.
    Vargo JA; Wegner RE; Heron DE; Ferris RL; Rwigema JC; Quinn A; Gigliotti P; Ohr J; Kubicek GJ; Burton S
    Head Neck; 2012 Aug; 34(8):1153-61. PubMed ID: 22076812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
    Ling DC; Vargo JA; Ferris RL; Ohr J; Clump DA; Yau WW; Duvvuri U; Kim S; Johnson JT; Bauman JE; Branstetter BF; Heron DE
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):973-980. PubMed ID: 27302512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer.
    Shikama N; Kumazaki Y; Tsukamoto N; Ebara T; Makino S; Abe T; Nakahira M; Sugasawa M; Kato S
    Jpn J Clin Oncol; 2013 Feb; 43(2):154-60. PubMed ID: 23242582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.